Search for Reversing Agents of Multidrug-Resistance in Tumor Cells from Marine Organisms
从海洋生物中寻找肿瘤细胞多药耐药性逆转剂
基本信息
- 批准号:10680567
- 负责人:
- 金额:$ 2.3万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In the course of our study of bioactive substances from marine organisms, we focused on a search for reversing agents of multidrug resistance (MDR) in tumor cells. We used two kinds of MDR human epidermoid carcinoma cell lines, KB-C2 cells overexpressing P-glycoprotein (P-gp) and KB-CV60 cells overexpressing multidrug resistance associated protein (MRP) for the screening assay. We found that araguspongines conquered MDR in KB-C2 cells. Araguspongines were isolated from an Okinawan marine sponge of Xestospongia sp. and characterized as macrocyclic dimer of 2,9-disubstituted 1-oxaquinolizidine. Araguspongine D, which is a major component among araguspongines, completely conquered MDR in KB-C2 cells at 10 μg/ml. Araguspongines B and E, which were stereoisomers of araguspongine D, also completely reversed MDR in KB-C2 cells. 5,5'-N-Dimethyl derivative and 2,2'-diol synthesized from araguspongine E did not show reversing activity. We isolated cembrane-type diterpenes reversing MDR in KB-C2 cells from a soft coral of Sinularia sp. This cembranoid completely conquered MDR in KB-C2 cells at 10 μg/ml. This cembranoid is seemed to be an artifact compound, which was produced from known natural cembranolide by addition of n-BuOH. We synthesized a series of cembrane derivatives replaced the n-butyl ester with various alcohols and found that the reversing activity of those derivatives were related to the carbon number of alcohol. Agosterol A, a novel polyhydroxylated sterol acetate, was isolated from a marine sponge of Spongia sp. as a reversing agent of MDR. Agosterol A perfectly reversed resistance to colchitine in KB-C2 cells and resistance to vincristine in KB-CV60 cells at 3μM concentration. Agosterol A recovered the accumulation of vincristine in KB-C2 and KB-CV60 cells to the level equal to that of parental KB 3-1 cells at 3 μM concentration.
在海洋生物活性物质的研究过程中,我们的重点是寻找肿瘤细胞中多药耐药(MDR)的逆转剂。我们使用过表达p -糖蛋白(P-gp)的KB-C2细胞和过表达多药耐药相关蛋白(MRP)的KB-CV60细胞两种MDR人表皮样癌细胞进行筛选。我们发现,在KB-C2细胞中,蜘蛛碱能够攻克耐多药耐药。从日本冲绳海绵中分离得到一种巨环2,9-二取代- 1-草喹喹啉二聚体。在10 μg/ml的浓度下,阿拉木皂素D完全攻克了KB-C2细胞的MDR。槟榔素B和E是槟榔素D的立体异构体,也能完全逆转KB-C2细胞的MDR。由木棉素E合成的5,5′- n -二甲基衍生物和2,2′-二醇不具有逆转活性。我们从Sinularia sp.软珊瑚中分离出逆转KB-C2细胞MDR的膜型二萜,这种膜类物质在10 μg/ml浓度下完全克服了KB-C2细胞的MDR。这种类胶质物质似乎是一种人造化合物,它是由已知的天然胶质内酯通过添加n-BuOH而产生的。我们合成了一系列用不同醇取代正丁基酯的膜衍生物,发现这些衍生物的逆转活性与醇的碳数有关。从海绵中分离出一种新型的多羟基化醋酸甾醇A作为耐多药的逆转剂。Agosterol A在3μM浓度下完全逆转了KB-C2细胞对秋几丁碱的抗性和KB-CV60细胞对长春新碱的抗性。Agosterol A使KB- c2和KB- cv60细胞长春新碱的积累恢复到3 μM浓度下与亲本KB- 3-1细胞相当的水平。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
N. Murakami: "Total synthesis of callystatin A, a potent cytotoxic polyketide from the marine sponge, Callyspongia truncata"Tetrahedron Lett.. 39. 23498-2352 (1998)
N. Murakami:“callystatin A 的全合成,一种来自海洋海绵 Callyspongia truncata 的有效细胞毒性聚酮化合物”Tetrahedron Lett.. 39. 23498-2352 (1998)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
S.Aoki: "Agostereol A, a novel polyhydroxylated sterol acetate reversing multidrug resistance from a marine sponge of spongia sp"Tetrahedron Letter. 39. 6303-6306 (1998)
S.Aoki:“Agostereol A,一种新型多羟基化甾醇乙酸酯,可逆转海绵的多药耐药性”四面体信件。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
S.Aoki: "Agosterol A, a novel polyhydroxylated sterol acetate rerersing multidrug resistance from marine sponge of spongia SP" Tetrahedron Lett. 39. 6303-6306 (1998)
S.Aoki:“Agosterol A,一种新型多羟基化甾醇乙酸酯,可逆转海绵 SP 的多药耐药性”四面体 Lett。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KOBAYASHI Motomasa其他文献
KOBAYASHI Motomasa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KOBAYASHI Motomasa', 18)}}的其他基金
Creation of novel molecular-targeted anticancer drugs focused on specific phenotypic changes of cells in tumor
开发专注于肿瘤细胞特定表型变化的新型分子靶向抗癌药物
- 批准号:
26242074 - 财政年份:2014
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Development of short-step synthesis of probe molecules for accelerating target identification
开发探针分子的短步合成以加速目标识别
- 批准号:
25560402 - 财政年份:2013
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Establishment of in vivo screening system using Medaka fish toward to the drug discovery
建立利用青鳉鱼进行药物发现的体内筛选系统
- 批准号:
22659002 - 财政年份:2010
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Investigation of benthonic marine organisms in Indonesia searching for new medicinal seeds.
对印度尼西亚底栖海洋生物进行调查,寻找新的药用种子。
- 批准号:
21406002 - 财政年份:2009
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Search for Bioactive Natural Products for Molecular Target Chemotherapy of Cancer
寻找用于癌症分子靶向化疗的生物活性天然产物
- 批准号:
18201042 - 财政年份:2006
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Investigation of Indonesian Marine Organisms as Medicinal Resources
印度尼西亚海洋生物作为药用资源的调查
- 批准号:
15406005 - 财政年份:2003
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Search for inhibitors of cell cycle and development for natural molecular probe
细胞周期抑制剂的寻找及天然分子探针的开发
- 批准号:
15310148 - 财政年份:2003
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Search for Indonesian Marine Life as Medicinal Resource (2)
寻找印度尼西亚海洋生物作为药用资源 (2)
- 批准号:
11691208 - 财政年份:1999
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Search for New Anti-tumor Lead Compounds from Marine Organisms
从海洋生物中寻找新的抗肿瘤先导化合物
- 批准号:
10557233 - 财政年份:1998
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Search for Indonesian Marine Life as Medicinal Resource
寻找印度尼西亚海洋生物作为药用资源
- 批准号:
09041184 - 财政年份:1997
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for international Scientific Research
相似国自然基金
P-glycoprotein与Rack1和Src相互作用并促进耐药乳腺癌细胞侵袭转移的分子机制研究
- 批准号:81472474
- 批准年份:2014
- 资助金额:85.0 万元
- 项目类别:面上项目
相似海外基金
Inhibition or evasion of P-glycoprotein-mediated drug transport
抑制或逃避 P-糖蛋白介导的药物转运
- 批准号:
10568723 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
Physiological function of P-glycoprotein in sanctuary tissue barriers in teleosts
P-糖蛋白在硬骨鱼保护区组织屏障中的生理功能
- 批准号:
RGPIN-2020-04905 - 财政年份:2022
- 资助金额:
$ 2.3万 - 项目类别:
Discovery Grants Program - Individual
Studies of P-glycoprotein Drug Interactions - Administrative Supplement for Undergraduate Summer Research
P-糖蛋白药物相互作用的研究 - 本科生暑期研究行政补充
- 批准号:
10810072 - 财政年份:2022
- 资助金额:
$ 2.3万 - 项目类别:
Bacterial targeting of the P-glycoprotein/endocannabinoid axis for reducing intestinal inflammation in ulcerative colitis
细菌靶向 P-糖蛋白/内源性大麻素轴以减少溃疡性结肠炎的肠道炎症
- 批准号:
10537517 - 财政年份:2022
- 资助金额:
$ 2.3万 - 项目类别:
Drug, Nucleotide, and Lipid Interactions with P-glycoprotein
药物、核苷酸和脂质与 P-糖蛋白的相互作用
- 批准号:
10672242 - 财政年份:2022
- 资助金额:
$ 2.3万 - 项目类别:
Mechanisms of suicide attempts by loss of P-glycoprotein function in the blood-brain barrier
血脑屏障中 P-糖蛋白功能丧失导致自杀未遂的机制
- 批准号:
22K06774 - 财政年份:2022
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Studies of P-glycoprotein Drug Interactions - Administrative Supplement for Equipment Purchase
P-糖蛋白药物相互作用研究-设备采购行政补充
- 批准号:
10795338 - 财政年份:2022
- 资助金额:
$ 2.3万 - 项目类别:
Physiological function of P-glycoprotein in sanctuary tissue barriers in teleosts
P-糖蛋白在硬骨鱼保护区组织屏障中的生理功能
- 批准号:
RGPIN-2020-04905 - 财政年份:2021
- 资助金额:
$ 2.3万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




